Reduction in concentration of total serum-bilirubin in offspring of women treated with phenobarbitone during pregnancy.
D001663:Bilirubin / Q000097:blood*; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000517:prevention & control; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D010634:Phenobarbital / Q000627:therapeutic use*; D011247:Pregnancy
D001663:Bilirubin; D010634:Phenobarbital